These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
81 related articles for article (PubMed ID: 3209169)
1. [Bioequivalence of generic drugs: sense and nonsense]. Brune K; Dietzel K Fortschr Med; 1988 Nov; 106(33):16-7. PubMed ID: 3209169 [No Abstract] [Full Text] [Related]
2. [Generic drugs, bioavailability, and bioequivalence]. Palma-Aguirre JA Gac Med Mex; 1998; 134(4):491-4. PubMed ID: 9789395 [No Abstract] [Full Text] [Related]
3. [Bioequivalence of generic drugs]. Schwabe U Internist (Berl); 1988 Mar; 29(3):147-59. PubMed ID: 3288573 [No Abstract] [Full Text] [Related]
4. [Bioequivalence studies of pharmaceutical preparations]. Vetchý D; Frýbortová K; Rabisková M; Danecková H Cas Lek Cesk; 2007; 146(5):431-3. PubMed ID: 17554963 [TBL] [Abstract][Full Text] [Related]
5. Comments on the note for guidance on bioavailability and bioequivalence in the European Union. Calvo G Methods Find Exp Clin Pharmacol; 1998; 20 Suppl A():11. PubMed ID: 9800721 [No Abstract] [Full Text] [Related]
6. [Are therapeutic drugs freely interchangeable? Studies of bioavailability and bioequivalence]. Blume H Verh Dtsch Ges Inn Med; 1988; 94():411-9. PubMed ID: 3061214 [No Abstract] [Full Text] [Related]
8. [Bioequivalence and generic drugs. I. Studies of bioequivalence, considering the theoretical basis, design and use]. Zapater P; Horga JF Rev Neurol; 1999 Dec 16-31; 29(12):1235-46. PubMed ID: 10652753 [TBL] [Abstract][Full Text] [Related]
9. Clinical relevance of the bioavailability/bioequivalence controversy. Gottschalk LA J Clin Psychiatry; 1986 Sep; 47 Suppl():3-5. PubMed ID: 3528133 [TBL] [Abstract][Full Text] [Related]
10. Overview on bioavailability and bioequivalence. Kaplan SA Psychopharmacol Bull; 1976 Oct; 12(4):50-1. PubMed ID: 972989 [No Abstract] [Full Text] [Related]
11. Differentiating low-molecular-weight heparins based on chemical, biological, and pharmacologic properties: implications for the development of generic versions of low-molecular-weight heparins. Jeske WP; Walenga JM; Hoppensteadt DA; Vandenberg C; Brubaker A; Adiguzel C; Bakhos M; Fareed J Semin Thromb Hemost; 2008 Feb; 34(1):74-85. PubMed ID: 18393144 [TBL] [Abstract][Full Text] [Related]
12. Bioavailability of psychotropic drugs: historical perspective and pharmacokinetic overview. Ereshefsky L; Jann MW; Saklad SR; Davis CM J Clin Psychiatry; 1986 Sep; 47 Suppl():6-15. PubMed ID: 3528134 [TBL] [Abstract][Full Text] [Related]
13. Generic drugs: bioequivalence and bioavailability. Ansbacher R JAMA; 1988 Jan; 259(2):220. PubMed ID: 2826829 [No Abstract] [Full Text] [Related]
15. Bioequivalence and narrow therapeutic index drugs. Benet LZ; Goyan JE Pharmacotherapy; 1995; 15(4):433-40. PubMed ID: 7479195 [TBL] [Abstract][Full Text] [Related]
16. Comparing generic and innovator drugs: a review of 12 years of bioequivalence data from the United States Food and Drug Administration. Davit BM; Nwakama PE; Buehler GJ; Conner DP; Haidar SH; Patel DT; Yang Y; Yu LX; Woodcock J Ann Pharmacother; 2009 Oct; 43(10):1583-97. PubMed ID: 19776300 [TBL] [Abstract][Full Text] [Related]
17. [Assessment of bioequivalence]. Aoyagi N Eisei Shikenjo Hokoku; 1996; (114):141-2. PubMed ID: 9037886 [TBL] [Abstract][Full Text] [Related]